Huntington’s Disease Pipeline Report, 2021 : Insights into the Current Therapies, Emerging Drugs, and Treatment Outlook | DelveInsight | Key Companies – Roche, Neurocrine Biosciences, EIP Pharma, Vaccinex, SOM Biotech, and Others

Huntington’s Disease Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Huntington’s Disease Market. 

The assessment part of the report embraces in-depth Huntington’s Disease commercial assessment and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, licensing, mergers, and acquisition, funding, designations, and other product-related details.

Huntington’s Disease Pipeline Analysis

The report provides insights into: 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Huntington’s Disease with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Huntington’s Disease treatment.
  • Huntington’s Disease key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Huntington’s Disease Drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Huntington’s Disease market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. 

Huntington’s Disease Therapeutics Analysis 

The dynamics of Huntington’s Disease is anticipated to change in the coming years owing to the improvement in the diagnosed methodologies and incremental healthcare spending across the world. 

Several companies are developing late- and mid-stage products constructing a dynamic pipeline for Huntington’s disease. Owing to the positive outcomes of the potential candidates during the developmental stage by the key players hold the potential to create a significant positive shift in the Market Size and treatment scenario.

Some of the key companies in the Huntington’s Disease Market include:

  • Hoffmann-La Roche 
  • Neurocrine Biosciences
  • EIP Pharma
  • Vaccinex
  • SOM Biotech SL

And several others

Huntington’s Disease Therapies covered in the report includes:

  • RG6042 
  • Valbenazine
  • Neflamapimod
  • Pepinemab
  • SOM3355

And many more

Get a more in-depth assessment into the pipeline therapies and key companies @

Report Highlights

  • A better understanding of disease pathogenesis contributes to the development of novel therapeutics for Huntington’s Disease.    
  • In the coming years, the Huntington’s Disease market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. 
  • The companies and academics are working to assess challenges and seek opportunities that could influence Huntington’s Disease Research & Development. The therapies under development are focused on novel approaches to treat/improve the disease condition.
  • A detailed portfolio of major pharma players involved in fueling the Huntington’s Disease treatment market with their potential therapies.
  • Our in-depth analysis of the Huntington’s Disease Pipeline Assets (in early-stage, mid-stage, and late stage of development) includes therapeutic assessment and comparative analysis. This will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities. 

Request for Huntington’s Disease Sample Pages @

Table of Content

  1. Report Introduction
  2. Huntington’s Disease 
  3. Huntington’s Disease Current Treatment Patterns
  4. Huntington’s Disease – DelveInsight’s Analytical Perspective
  5. Therapeutic Assessment
  6. Huntington’s Disease Late Stage Products (Phase-III)
  7. Huntington’s Disease Mid Stage Products (Phase-II)
  8. Early Stage Products (Phase-I)
  9. Pre-clinical Products and Discovery Stage Products
  10. Inactive Products
  11. Dormant Products
  12. Huntington’s Disease Discontinued Products
  13. Huntington’s Disease Product Profiles
  14. Huntington’s Disease Key Companies
  15. Huntington’s Disease Key Products
  16. Dormant and Discontinued Products
  17. Huntington’s Disease Unmet Needs
  18. Huntington’s Disease Future Perspectives
  19. Huntington’s Disease Analyst Review  
  20. Appendix
  21. Report Methodology

*The table of contents is not exhaustive; the final content may vary. 

Request for a more detailed ToC, Tables, and Figures included in the report @

Latest Reports By DelveInsight:

Huntington’s Disease Market Insight

DelveInsight’s “Huntington’s Disease Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Huntington’s Disease market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Huntington’s Disease Epidemiology Forecast

DelveInsight’s Huntington’s Disease Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Huntington’s Disease in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Total Knee Arthroplasty Market

DelveInsight’s ‘Total Knee Arthroplasty -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of Total Knee Arthroplasty and the historical and forecasted Total Knee Arthroplasty market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

Latest HealthCare Blogs By DelveInsight:

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Info:
Shruti Thakur
DelveInsight Business Research LLP
Phone No: +91-9650213330
Email: [email protected]
Connect With Us: LinkedIn | Facebook | Twitter
For Latest Update: Healthcare Blog
Request for Sample Copy of the Report at:

Leave a Reply

Your email address will not be published. Required fields are marked *